You are here: Home1 / Chikungunya
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:46:152025-02-13 14:09:54New approach: MHC class I peptide libraries for the treatment of viral and bacterial infectious diseases by innovative multi-epitope T cell adaptive vaccines
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:41:032025-02-18 09:48:29Emergex’s Next Generation Vaccines: Naturally processed & presented MHC class I ligandome libraries for the development of T cell priming immune set-point vaccines against infectious pathogens
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:39:392025-02-13 14:03:16Label-free quantitative proteomics characterizes immunopathogenesis of Chikungunya virus infection in hepatocellular carcinoma cells
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:26:592025-02-13 13:59:11Characterization of the immunogenic response of a Chikungunya virus T cell adaptive vaccine
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 13:07:542025-02-13 13:57:52Novel immunopeptidomic/machine learning integrated platform for next generation Chikungunya T cell priming vaccine development
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 08:09:312025-03-19 09:58:09Emergex T cell Chikungunya Vaccine: A Model for Emergex’s Synthetic T Cell Vaccine Platform as a Solution to Combat Alphaviruses Supporting Biothreat Preparedness
/wp-content/uploads/2024/10/CompanyName-300x300.png
0
0
gatekeeper
/wp-content/uploads/2024/10/CompanyName-300x300.png
gatekeeper2025-02-13 08:07:142025-04-23 14:42:16ChikungunyaTcP: characterization of the immunogenic response of a novel CD8 T cell priming vaccine against Chikungunya virus
Scroll to top
